Related Experiment Video
Updated: Oct 1, 2026

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
Published on: May 21, 2015
Mechanisms of Complement Activation and NETosis Interplay in Early Pregnancy Loss: From Autoimmunity to
Junxian Ma1,2, Kexin Wang1, Guosheng Li1
1Reproductive Medicine Center, The Second Hospital & Clinical Medical School, Lanzhou University, 730030 Lanzhou, Gansu, China.
Abstract:
Early Pregnancy Loss (EPL) represents a formidable challenge in reproductive medicine. Its complex pathophysiology is primarily characterized by dysregulation of both the immune and coagulation systems. In recent years, abnormal activation of the complement system and neutrophil extracellular trap formation (NETosis) have received increasing scientific attention as key molecular events underlying EPL. This interest is fueled significantly by compelling evidence from non-pregnant models, such as antiphospholipid syndrome (APS) and severe infections (e.g., COVID-19), which demonstrate a pathogenic synergy between complement and NETosis in thrombo-inflammatory pathways. Dysregulation of the complement system can trigger strong inflammatory responses and promote a prothrombotic state. Similarly, excessive NETosis acts as a significant driver of tissue damage and thrombosis. This review aims to systematically delineate the complex crosstalk between complement activation and NETosis in EPL, with particular emphasis on their bidirectional regulatory relationship within autoimmune and thrombo-inflammatory pathways. By thoroughly analyzing the critical pathological role of this "complement-NETosis axis" in disrupting uteroplacental interface homeostasis and ultimately causing pregnancy failure, this review not only presents an integrative conceptual framework for comprehensively understanding the molecular mechanisms of EPL, but, more importantly, proposes a novel hypothesis, based on mechanistic insights derived from non-pregnant models, that this axis may play acentral role in EPL. This perspective provides a framework for future research, encompassing the validation of associated potential biomarkers and the exploration of targeted intervention strategies, thereby holding promise for advancing precise clinical intervention paradigms for specific EPL subtypes.
Related Concept Videos
Complement System
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Clot Retraction and Fibrinolysis
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
